-+ 0.00%
-+ 0.00%
-+ 0.00%

Whitehawk Therapeutics Q3 EPS $(0.26) Misses $0.07 Estimate

Benzinga·11/06/2025 13:37:52
Listen to the news
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.07 by 488.06 percent. This is a 43.48 percent increase over losses of $(0.46) per share from the same period last year.